Edit |   |
---|---|
Antigenic Specificity | IL13, Human (Tralokinumab biosimilar) |
Clone | Tralokinumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, FCM, IP, FuncS, IF, Neut |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL13 Recombinant Antibody (Tralokinumab). Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, [1] and is designed for the treatment of asthma and other inflammatory diseases.[2] Tralokinumab was discovered by Cambridge Antibody Technology scientists, using Ribosome Display, as CAT-354[3] and taken through pre-clinical and early clinical development. |
Immunogen | n/a |
Other Names | Anti-IL13 Recombinant Antibody, Research Grade Tralokinumab, Anti-Human IL13 Recombinant Antibody(Tralokinumab), CAT-354, Antibody Drug Analogues, Monoclonal Antibody, YR1107, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1044515-88-9 |
Catalog # | YR1107 |
Price | please inquire |
Order / More Info | IL13, Human (Tralokinumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |